Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 4
2012 2
2014 1
2015 2
2017 2
2018 4
2019 6
2020 5
2021 7
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Neuroblastoma.
Mahapatra S, Challagundla KB. Mahapatra S, et al. Among authors: challagundla kb. 2023 Jul 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jul 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 28846355 Free Books & Documents.
Targeting IκappaB kinases for cancer therapy.
Awasthee N, Rai V, Chava S, Nallasamy P, Kunnumakkara AB, Bishayee A, Chauhan SC, Challagundla KB, Gupta SC. Awasthee N, et al. Among authors: challagundla kb. Semin Cancer Biol. 2019 Jun;56:12-24. doi: 10.1016/j.semcancer.2018.02.007. Epub 2018 Feb 24. Semin Cancer Biol. 2019. PMID: 29486318 Free PMC article. Review.
Past, Present, and a Glance into the Future of Multiple Myeloma Treatment.
Elbezanti WO, Challagundla KB, Jonnalagadda SC, Budak-Alpdogan T, Pandey MK. Elbezanti WO, et al. Among authors: challagundla kb. Pharmaceuticals (Basel). 2023 Mar 8;16(3):415. doi: 10.3390/ph16030415. Pharmaceuticals (Basel). 2023. PMID: 36986514 Free PMC article. Review.
Bruton's Tyrosine Kinase Targeting in Multiple Myeloma.
Von Suskil M, Sultana KN, Elbezanti WO, Al-Odat OS, Chitren R, Tiwari AK, Challagundla KB, Srivastava SK, Jonnalagadda SC, Budak-Alpdogan T, Pandey MK. Von Suskil M, et al. Among authors: challagundla kb. Int J Mol Sci. 2021 May 27;22(11):5707. doi: 10.3390/ijms22115707. Int J Mol Sci. 2021. PMID: 34071917 Free PMC article. Review.
Immune checkpoint molecules in neuroblastoma: A clinical perspective.
Pathania AS, Prathipati P, Murakonda SP, Murakonda AB, Srivastava A, Avadhesh, Byrareddy SN, Coulter DW, Gupta SC, Challagundla KB. Pathania AS, et al. Among authors: challagundla kb. Semin Cancer Biol. 2022 Nov;86(Pt 2):247-258. doi: 10.1016/j.semcancer.2022.06.013. Epub 2022 Jul 3. Semin Cancer Biol. 2022. PMID: 35787940 Review.
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges.
Pathania AS, Prathipati P, Abdul BA, Chava S, Katta SS, Gupta SC, Gangula PR, Pandey MK, Durden DL, Byrareddy SN, Challagundla KB. Pathania AS, et al. Among authors: challagundla kb. Theranostics. 2021 Jan 1;11(2):731-753. doi: 10.7150/thno.51471. eCollection 2021. Theranostics. 2021. PMID: 33391502 Free PMC article. Review.
PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective.
Nallasamy P, Chava S, Verma SS, Mishra S, Gorantla S, Coulter DW, Byrareddy SN, Batra SK, Gupta SC, Challagundla KB. Nallasamy P, et al. Among authors: challagundla kb. Semin Cancer Biol. 2018 Oct;52(Pt 2):53-65. doi: 10.1016/j.semcancer.2017.11.009. Epub 2017 Nov 28. Semin Cancer Biol. 2018. PMID: 29196189 Free PMC article. Review.
SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges.
Coke CJ, Davison B, Fields N, Fletcher J, Rollings J, Roberson L, Challagundla KB, Sampath C, Cade J, Farmer-Dixon C, Gangula PR. Coke CJ, et al. Among authors: challagundla kb. J Clin Med. 2021 Jan 5;10(1):156. doi: 10.3390/jcm10010156. J Clin Med. 2021. PMID: 33466289 Free PMC article. Review.
35 results